Advertisement

Prediabetes pp 33-41 | Cite as

Spontaneous Diabetes in MacacaNigra: Relevance to Human Beings with NIDDM

  • Charles F. HowardJr.
Part of the Advances in Experimental Medicine and Biology book series (AEMB, volume 246)

Abstract

Classification of human diabetes mellitus based on a functional or pathological lesion has helped to clarify research issues and indicate research directions. However, there is increasing awareness of heterogeneity within each classification. An ancillary result of awareness of the heterogeneity is a greater focus on subgroups of individuals and attempts to define exact etiologies based on signs, symptoms, and secondary manifestations.

Keywords

Beta Cell Islet Cell NIDDM Patient Islet Cell Antibody Intravenous Glucose Tolerance Test 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Bell, E.T., 1952, Hyalinization of the islets of Langerhans in diabetes mellitus. Diabetes 1: 341–344.PubMedGoogle Scholar
  2. 2.
    Ludwig, V.G., Heitner, H., 1967, Zur Häufigkeit der inselamyloidose des Pankreas beim diabetes mellitus. Zeitschrift Fur Die Gesmate Innere Medizin Und Ihre Grenzgebiete 22L 814–829.Google Scholar
  3. 3.
    Cooper, G.J.S., Willis, A.C., Clark, A., Turner, R.C., Sim, R.B., and Reid, K.B.M., 1987, Purification and characterization of a peptide from amyloid-rich pancreases of type 2 diabetic patients. Proc Natl Acad Aci USA, 84: 8628–8632.CrossRefGoogle Scholar
  4. 4.
    Westermark, P., Wernstedt, C., Wilander, E., Hayden, D.W., O’Brien, T.D., and Johnson, K.H., Amyloid fibrils in human insulinoma and islets of Langerhans of the diabetic cat are derived from a neuropeptide-like protein also present in normal islet cells. Proc Natl Acad Sci USA 84: 38881–3885.Google Scholar
  5. 5.
    Howard, C.F., Jr., 1978, Insular amyloidosis and diabetes mellitus in Macaca nigra. Diabetes 27: 357–364.PubMedCrossRefGoogle Scholar
  6. 6.
    Howard, C.F., Van Bueren, A., 1986, Changes in islet cell composition during development during development of diabetes in Macaca nigra. Diabetes 35: 165–171.PubMedCrossRefGoogle Scholar
  7. 7.
    Howard, C.F., Fang, T-Y., 1984, Islet cell cytoplasmic antibodies Macaca nigra. Diabetes 33: 219–223.PubMedCrossRefGoogle Scholar
  8. 8.
    Fang, T.-Y., Van Bueren, T., Howard, C.F., Jr., 1988. Reaction patterns of islet cell autoantibody in Macaca nigra. Pancreas. In press.Google Scholar
  9. 9.
    Irvine, W.J., Sawer, J.S.A., Feek, C.M., Prescott, R.J., Duncan, L.J.P., 1979, The value of islet cell antibody in predicting secondary failure of oral hypoglycaemic agent therapy in diabetes mellitus. J Clin Lab Immunol 2: 23–26.PubMedGoogle Scholar
  10. 10.
    Maloy, A.L., Longnecker, D.S., Greenberg, E.R., 1981, The relation of islet amyloid ot the clinical type of diabetes. Hum Pathol 12: 917–922.PubMedCrossRefGoogle Scholar

Copyright information

© Plenum Press, New York 1988

Authors and Affiliations

  • Charles F. HowardJr.
    • 1
  1. 1.Oregon Regional Primate Research CenterBeavertonUSA

Personalised recommendations